Platelet Aggregation and Nutritional Status in Insulin Dependent Diabetes mellitus

• References

• 1 Cho NH, Becker D, Dorman JH, Wolfson S, Kuller LH, Drash AL, Follansbee WF, Kelsey SF, Orchard TJ. Spontaneous whole blood platelet aggregation in insulin-dependent diabetes mellitus: an evaluation in an epidemiologic study. Thromb Haemostas 1989; 61: 127-130
• 2 Kwaan HC, Colwell JA, Crus S, Suwanwela N, Dobbie JG. Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 1972; 80: 236-246
• 3 Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 1975; 82: 733-738
• 4 Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RMG. Altered platelet function in diabetes mellitus. Diabetes 1976; 25 Suppl (Suppl. 02) 826-831
• 5 Ziboh VA, Maruta H, Lord J, Cagle WD, Lucky W. Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur J Clin Invest 1979; 09: 223-228
• 6 Butkus A, Skrinska VA, Schumacher OP. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 1980; 19: 211-223
• 7 Halushka PV, Rogers RC, Loadholt CB, Colwell JA. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 1981; 97: 87-96
• 8 Ylikorkala O, Kaila J, Viinikka L. Prostacyclin and thromboxane in diabetes. Br Med J 1981; 283: 1148-1150
• 9 McDonald JW D, Dupre J, Rodger NW, Champion MC, Webb CD, Ali M. Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thromb Res 1982; 28: 705-712
• 10 Butkus A, Shirey EK, Schumacher OP. Thromboxane biosynthesis in platelets from diabetic and coronary artery diseased patients. Artery 1982; 11: 238-251
• 11 Betteridge DJ, El Tahir KE H, Reckless JP D, Williams KI. Platelets from diabetic subjects show diminished sensitivity to prostacyclin. Eur J Clin Invest 1982; 12: 395-398
• 12 Kubisz P, Arabi A, Holan J, Cronberg S. Investigations on platelet function in diabetes mellitus. Haemostasis 1984; 14: 347-353
• 13 DiMinno G, Silver MJ, Cerbone AM, Riccardi G, Rivellese A, Mancini M, Thiagarajan P. Increased binding of fibrinogen to platelets in diabetes: The role of prostaglandins and thromboxane. Blood 1985; 65: 156-162
• 14 Greco NJ, Arnold JH, O’Dorisio TM, Cataland S, Panganamala RV. Action of platelet-activating factor on type 1 diabetic human platelets. J Lab Clin Med 1985; 105: 410-416
• 15 DiMinno G, Silver MJ, Cerbone AM, Riccardi G, Rivellese A, Mancini M. Platelet fibrinogen binding in diabetes mellitus. Diabetes 1986; 35: 182-185
• 16 Breddin K, Grun H, Krzywanek HJ, Schremmer WP. On the measurement of spontaneous platelet aggregation. The platelet aggregation test III Thromb Haemostas 1976; 35: 669-691
• 17 Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M. Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res 1980; 19: 823-830
• 18 Onodera H, Hirata T, Sugawara H, Sugai K, Yoda B, Toyota T, Goto Y. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients. Tohoky J Exp Med 1982; 137: 423-428
• 19 Silberbauer K, Schernthaner G, Sinzinger H, Freyler H. Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography. Atherosclerosis 1981; 40: 81-90
• 20 Koneti Rao A, Goldberg RE, Walsh PN. Platelet coagulant activities in diabetes mellitus. J Lab Clin Med 1984; 103: 82-92
• 21 Kutti J, Wadenvik H, Henestam B, Stenström G. Evaluation of platelet reactivity in diabetes mellitus. Acta Med Scand 1986; 219: 195-199
• 22 Daví G, Rini GB, Averna M, Novo S, Di Fede G, Pinto A, Notarbartolo A, Strano A. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-dependent diabetics. Thromb Res 1982; 26: 359-370
• 23 Alessandrini P, McRae S, Fernan S, FitzGerald GA. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. N Engl J Med 1988; 319: 208-212
• 24 Landgraf-Leurs M MC, Ladik T, Smolka B, Bock T, Schramm W, Spannagl M, Landgraf R. Increased thromboplastic potential in diabetes. Wochenschr 1987; 65: 600-606
• 25 Davis JW, Phillips PE, Yue K TN, Lewis HD, Hartman CR. Platelet aggregation, adult-onset diabetes mellitus and coronary artery disease. J Am Med Assoc 1978; 239: 732-734
• 26 Petersen HD, Gormsen J. Platelet aggregation in diabetes mellitus. Acta Med Scand 1978; 203: 125-130
• 27 Fritschi J, Christe M, Laemmle B, Marbet GA, Berger W, Duckert F. Platelet aggregation, βthromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 1984; 52: 236-239
• 28 Kazmier FJ, Bowie E JW, O,Fallon WN, Zimmerman BR, Osmundson PJ, Palumbo PJ. A prospective study of peripheral occlusive arterial disease in diabetes IV Platelet and plasma functions. Mayo Clin Proc 1981; 56: 243-253
• 29 Sterky C CG, Persson B EE, Larsson Y AA. Dietary fats, the diurnal blood lipids and ketones in juvenile diabetes. Diabetologia 1966; 2: 14-19
• 30 Hoak JC, Warner ED, Connor WE. Platelets, fatty acids and thrombosis. Circul Res 1967; 20: 11-17